Abstract Human T cell lymphotropic virus type 1 (HTLV-1) is endemic in many regions of the world, including Brazil, and has been associated to several immunological manifestations such as arthritis, uveitis, dermatitis and Sjögren's syndrome. This study was intended to evaluate the frequency of autoantibodies in patients infected with HTLV-1 and manifesting keratoconjunctivitis sicca (KCS). HTLV-1 patients with KCS, enrolled in a reference ambulatory of the city of Salvador, were tested for autoantibodies such as antinuclear antibodies, rheumatoid factor, anti-SSA/Ro and anti-SSB/La. Two comparison groups were also included: (a) HTLV-1 patients without KCS and (b) seronegative patients with KCS. Correlation of proviral load (PVL) in HTLV-1 patients with presence or absence of KCS was also assessed. No autoantibodies were detected in HTLV-1 patients with KCS. The PVL of HTLV-1 patients was higher in patients with KCS without other clinical manifestations customarily associated to HTLV-1. In conclusion, in this study, no changes were observed in humoral immunity concerning production of certain autoantibodies in HTLV-1-infected patients with KCS, which suggests that other mechanisms may be involved in the pathogenesis of this manifestation. Additionally, PVL may be a marker of KCS development in these patients.
Introduction
Retroviruses were Wrst described in the beginning of the last century, but the causal relationship with human diseases was only established in the early 1980s when human T cell lymphotropic virus type 1 (HTLV-1) was identiWed as an etiologic agent of leukemias and lymphomas [1] .
This virus has shown high levels of endemicity in some regions of the globe, such as southwest Japan, the Caribbean, Central and South America, Melanesia and Africa [2] . In Brazil, it is estimated that 750,000 subjects are infected [3] and in the city of Salvador, a recent seroprevalence study has shown that 1.7% of the population is infected [4] , the highest seroprevalence found in the country.
Two clinical conditions were initially associated to infection by HTLV-1-adult T cell leukemia-lymphoma [5] and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) [6] . Additionally, many authors have demonstrated a possible causal relationship between cases of arthritis [7, 8] , polymyositis [9] and Sjögren's syndrome (SS) [10, 11] suggests direct action of this agent on auto-immunity. Ophthalmological manifestations such as uveitis [12] , corneal changes [13, 14] and keratoconjunctivitis sicca (KCS) [15, 16] [17] may also occur:
This study was intended to evaluate the presence of certain autoantibodies in patients with HTLV-1 infection complicated by KCS, and to investigate association between the proviral load (PVL) and this complication.
Materials and methods

Subjects
Three subject cohorts were investigated. Patients who refused to participate in the project were excluded from the study, as well as patients with KCS secondary to other previously diagnosed diseases, such as Steven-Johnson syndrome, ocular burns, eyelid occlusion deWcit, collagen vascular diseases, previous herpes virus infection and refractive surgeries.
In addition to the complete ophthalmological examination and the lacrimal function tests, all patients underwent serum tests for autoantibodies: antinuclear antibodies (ANA) by indirect immunoXuorescence on HEp-2 cells, rheumatoid factor (RF) by nephelometry and anti-SSA/Ro and anti-SSB/La tested by ELISA. Additionally, PVL was quantiWed in subjects of cohorts I and II (HTLV-1-infected) using the "TaqMan real-time PCR assay" [19] .
Statistical analysis was conducted using the software Statistical Package for the Social Sciences (SPSS Chicago, IL, version 13). Some results were expresses as a mean § standard deviation. The Mann-Whitney test was used for median comparison, after testing the normality of quantitative variables. The normality was tested using the D'Agostino Pearson method. For all statistical tests, a P value <0.05 was considered. The study was approved by the Ethics Committee of Hospital Santa Izabel and all patients signed an informed consent form before entering the study.
Results
Cohorts I and II had 15 patients each, of which six were males (40.0%) and nine females (60.0%), with mean age of 53.1 § 14.2 years in the Wrst cohort and 50 § 13.1 years in the second. Cohort III was composed of 14 patients, of which two were males (14.3%) and 12 females (85.7%), with mean age of 61.21 § 12.3 years. Nine patients in group I and six patients in group III also had xerostomia as deWned by European Community Criteria for SS. Regarding the severity of KCS, all patients in group I were graded as stage 1 whereas in group III, nine were in stage 1 and Wve in stage 2.
Of the HTLV-1-positive patients with KCS (cohort I), seven were asymptomatic carriers (46.6%) and eight (53.3%) has virus-related diseases; HAM/TSP was conWrmed in six patients (40.0%). Among the HTLV-1-positive patients without KCS diagnosis (cohort II), nine (60%) were asymptomatic. Six (40.0%) presented with HTLV-1-related clinical changes, and HAM/TSP was conWrmed in three patients (20%) ( Table 1) .
In cohorts I and III, no patients was positive for ANA, anti-SSA/Ro, anti-SSB/La or RF, while three of the 15 patients of cohort II (20%) were positive for RF and negative for other autoantibodies.
When evaluating all HTLV-1 carrier patients (with or without KCS), it was observed that the mean PVL was higher in patients with KCS (125,891 copies) than in patients with preserved lacrimal function (57,555 copies); however, no statistical signiWcance was achieved (P = 0.06). Mean PVL was also higher in HAM/TSP carriers (195,394.8 copies) than in asymptomatic patients (46,131.81 copies) (P = 0.01).
There was no statistically signiWcant diVerence in the mean PVL among HAM/TSP carrier patients with KCS (191,545.50) and without KCS (203,093.30) (P = 0.9). However, in non-HAM/TSP patients the presence of KCS was associated to a higher mean PVL (85,058.63 copies in KCS patients and 11,481.56 in non-KCS patients), P = 0.01.
Discussion
HTLV-1-associated tear Wlm changes were initially noted by Green et al. [20] , when studying mice bearing the Tax gene and developing a SS-like clinical picture [20] . The association between SS and HTLV-1 in humans is dated 1992, when Eguchi et al. [10] found in an endemic zone higher prevalence of this virus among the carriers of the syndrome than in the seronegative control group. Curiously, clinical, laboratorial and histopathological similarities have been observed by many authors when comparing patients with SS who show positive or negative serology for HTVL-1. Thus, Hida et al. [21] compared the prevalence of autoantibodies in HTLV-1 positive and negative patients with SS, and did not Wnd any statistically signiWcant diVerences between the frequency of antibodies anti-SSA/Ro, anti-SSB/La, ANA and RF among the two groups investigated. Likewise, Nakamura et al. [22] observed that 65% of HAM/TSP patients had SS and, among these patients, 61% were positive for ANA and 38% had anti-SSA/Ro e anti-SSB/La antibodies. On the other hand, studies conducted in Martinica showed that in HTLV-I patients with KCS associated to inWltration of salivary glands conWrmed by biopsy graded according to the Chisholm scale [23] , the autoantibodies screening was negative for all patients investigated [16, 24] . The Wndings of the present study are similar to those results since SS-marker antibodies such as anti-SSA/Ro and anti-SSB/La were not found in the population of 30 HTLV-1-infected patients, regardless of the presence of KCS.
One limitation of this study is that other manifestations of SS, i.e., the presence of xerostomy and lip biopsy showing lymphocytic inWltrate were not explored and therefore the possibility of the absence of these antibodies being due to selection of cases without complete SS may not be excluded. Another theory is that the HTLV-1 strand existing in Brazil and Martinica might be diVerent from that existing in Japan, which allows inWltration of salivary and lacrimal glands by lymphocyte populations with diVerent capacities to produce autoantibodies. Anyhow, a conclusion can already be drawn from the Wndings of the present study: the presence of KCS in HTLV-1 patients does not seem to depend on the production of the antibodies as it occurs in most cases of "primary" SS.
Brazil is an endemic zone for HTLV-1 and some studies have conWrmed the ocular involvement associated to HTLV-1 [25] [26] [27] ; however, little has been investigated about the presence of autoantibodies in patients with manifestations of SS. An exception would be the study recently developed at another research site in the same city (Salvador), in which the authors also did not Wnd any anti-SSA/ Ro anti-SSB/La antibodies in HTLV-1-infected patients, even in those with clinical manifestations of SS [28] , which reinforces what has been commented before.
Some mechanisms have been proposed for the development of clinical SS manifestations in HTLV-1 carriers, such as: the virus might infect and activate anergic autoreactive T cells, breaking immunological tolerance; or cellular products bearing the HTLV-1 Tax gene might be candidate autoantigens or might lead to the activation of autoreactive T cells, thus resulting in SS [29] .
Despite the small number of subjects enrolled, which requires careful interpretation of statistical Wndings, another relevant Wnding of this study was the observation that patients with HTLV-1 and KCS free of any other clinical manifestation customarily associated to this infection showed a higher PVL than those without KCS. These data may suggest that PVL determination could be a marker of KCS development, similarly to what has been seen in patients with uveitis [30] . There is no information on whether this higher viral activity could also lead to inhibition of the production of autoantibodies, which could justify the negative serologic Wndings of our study. Association between KCS and the presence of HAM/TSP was also observed in our study and is corroborated by previous studies [31, 32] .
